← Open Payments lookup

JENNIFER CHIEPPA: Open Payments

NPI 1124402904 · SPRINGFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,065 in 111 payments from 38 companies in 2025. Trend: 2023 $2,029 · 2024 $2,483 · 2025 $3,065

Food & beverage: $1,844Long term medical supply or device loan: $1,000Education: $221
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation21$1,146
ABBVIE INC.12$219
Incyte Corporation5$177
Daiichi Sankyo Inc.4$141
Takeda Pharmaceuticals U.S.A., Inc.4$133
PFIZER INC.7$103
Bayer Healthcare Pharmaceuticals Inc.4$92
AstraZeneca Pharmaceuticals LP5$86
Aveo Pharmaceuticals, Inc.3$84
GlaxoSmithKline, LLC.4$78

Products named: KISQALI, Enhertu, FRUZAQLA, IBRANCE, FOTIVDA, ELAHERE, JAKAFI, Nubeqa.

Industry payments across NJ — which companies pay providers there.